Department of Orthopaedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
School of Mechanical and Electrical Engineering, Henan University of Technology, Zhengzhou, China.
J Biomed Mater Res A. 2024 Jul;112(7):1083-1092. doi: 10.1002/jbm.a.37689. Epub 2024 Feb 27.
Porous titanium exhibits low elastic modulus and porous structure is thought to be a promising implant in bone defect repair. However, the bioinert and low mechanical strength of porous titanium have limited its clinical application, especially in load-bearing bone defect repair. Our previous study has reported an infiltration casting and acid corrosion (IC-AC) method to fabricate a novel porous titanium (pTi) with 40% porosity and 0.4 mm pore diameter, which exerts mechanical property matching with cortical bone and interconnected channels. In this study, we introduced a nanoporous coating and incorporated an osteogenic element strontium (Sr) on the surface of porous titanium (named as Sr-micro arch oxidation [MAO]) to improve the osteogenic ability of the pTi by MAO. Better biocompatibility of Sr-MAO was verified by cell adhesion experiment and cell counting kit-8 (CCK-8) test. The in vitro osteogenic-related tests such as immunofluorescence staining, alkaline phosphatase staining and real-time polymerase chain reaction (RT-PCR) demonstrated better osteogenic ability of Sr-MAO. Femoral bone defect repair model was employed to evaluate the osseointegration of samples in vivo. Results of micro-CT scanning, sequential fluorochrome labeling and Van Gieson staining suggested that Sr-MAO showed better in vivo osteogenic ability than other groups. Taking results of both in vitro and in vivo experiment together, this study indicated the Sr-MAO porous titanium could be a promising implant load-bearing bone defect.
多孔钛具有较低的弹性模量,且其多孔结构被认为是一种很有前途的骨缺损修复植入物。然而,多孔钛的生物惰性和低机械强度限制了其在临床应用中的应用,尤其是在承重骨缺损的修复中。我们之前的研究报道了一种浸渗铸造和酸蚀(IC-AC)方法来制备一种新型的多孔钛(pTi),其孔隙率为 40%,孔径为 0.4mm,具有与皮质骨相匹配的机械性能和相互连通的通道。在本研究中,我们在多孔钛表面引入了纳米多孔涂层并掺入了成骨元素锶(Sr)(命名为 Sr-微弧氧化 [MAO]),通过 MAO 来提高 pTi 的成骨能力。细胞黏附实验和细胞计数试剂盒-8(CCK-8)试验验证了 Sr-MAO 更好的生物相容性。体外成骨相关试验,如免疫荧光染色、碱性磷酸酶染色和实时聚合酶链反应(RT-PCR),表明 Sr-MAO 具有更好的成骨能力。股骨骨缺损修复模型用于评估体内样品的骨整合情况。微 CT 扫描、连续荧光标记和 Van Gieson 染色的结果表明,Sr-MAO 具有比其他组更好的体内成骨能力。综合体内外实验结果表明,Sr-MAO 多孔钛有望成为一种有前途的承重骨缺损植入物。